• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人白细胞干扰素的分子大小异质性

Molecular size heterogeneity of human leukocyte interferon.

作者信息

Chadha K C, Sclair M, Sulkowski E, Carter W A

出版信息

Biochemistry. 1978 Jan 10;17(1):196-200. doi: 10.1021/bi00594a029.

DOI:10.1021/bi00594a029
PMID:618543
Abstract

Molecular sieving of human leukocyte interferon revealed an apparent molecular weight of 26,000. However, after denaturation by guanidine hydrochloride in the presence of a reducing agent and reactivation by extensive dialysis, a molecular weight of only 21,000 was observed. The reactivated human leukocyte interferon (mol wt 21,000) gave a single peak of activity when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, confirming that a single molecular weight species was generated by the denaturation and reactivation procedure. A partial unfolding of the molecule was evident when the interferon preparation was heated to 50 degrees C in the absence or presence of an unfolding agent and then sieved on Sephadex G-100 Superfine. These results suggest that the interferon molecule undergoes a proteolytic cleavage probably by a protease present in extracellular fluid. Thus, a peptide fragment dissociates from the parent molecule when human leukocyte interferon is denatured in the presence of a reducing agent, resulting in a drop of 5,000 in molecular weight; interestingly, the resultant 21,000 molecular weight form still retains its antiviral activity.

摘要

人白细胞干扰素的分子筛分析显示其表观分子量为26,000。然而,在还原剂存在的情况下用盐酸胍变性并通过广泛透析重新激活后,观察到分子量仅为21,000。当通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳分析时,重新激活的人白细胞干扰素(分子量21,000)呈现出单一的活性峰,证实变性和重新激活过程产生了单一分子量的物种。当干扰素制剂在不存在或存在变性剂的情况下加热至50℃,然后在Sephadex G - 100 Superfine上进行筛分,分子的部分解折叠是明显的。这些结果表明,干扰素分子可能被细胞外液中存在的蛋白酶进行蛋白水解切割。因此,当人白细胞干扰素在还原剂存在下变性时,一个肽片段从母体分子上解离,导致分子量下降5,000;有趣的是,所得的分子量为21,000的形式仍保留其抗病毒活性。

相似文献

1
Molecular size heterogeneity of human leukocyte interferon.人白细胞干扰素的分子大小异质性
Biochemistry. 1978 Jan 10;17(1):196-200. doi: 10.1021/bi00594a029.
2
Human leukocyte interferon: production, purification to homogeneity, and initial characterization.人白细胞干扰素:生产、纯化至均一性及初步特性鉴定
Proc Natl Acad Sci U S A. 1979 Feb;76(2):640-4. doi: 10.1073/pnas.76.2.640.
3
Separation of human leukocyte interferon components by concanavalin A-agarose affinity chromatography and their characterization.用伴刀豆球蛋白A-琼脂糖亲和层析法分离人白细胞干扰素组分及其特性鉴定
Biochemistry. 1979 Dec 25;18(26):5782-6. doi: 10.1021/bi00593a006.
4
Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation, and cross-species antiviral activity.人白细胞干扰素的分子异质性:存在两种分子量、复性要求及种间抗病毒活性不同的群体。
Virology. 1975 Sep;67(1):68-73. doi: 10.1016/0042-6822(75)90403-1.
5
Size characteristics of human leucocyte interferon under reducing and non-reducing conditions.还原和非还原条件下人白细胞干扰素的大小特征
Biochem J. 1981 Mar 1;193(3):947-51. doi: 10.1042/bj1930947.
6
Human leukocyte interferon purified to homogeneity.纯化至同质的人白细胞干扰素。
Science. 1978 Dec 22;202(4374):1289-90. doi: 10.1126/science.725605.
7
Production and purification of human leukocyte interferon.人白细胞干扰素的生产与纯化
Jpn J Microbiol. 1974 Jan;18(1):21-7. doi: 10.1111/j.1348-0421.1974.tb00739.x.
8
Human lymphoblastoid interferon. Large scale production and partial purification.人淋巴母细胞干扰素。大规模生产与部分纯化。
J Biol Chem. 1977 Oct 10;252(19):6585-7.
9
Nature of the molecular heterogeneity of human leukocyte interferon.人白细胞干扰素的分子异质性本质
J Virol. 1976 Aug;19(2):425-34. doi: 10.1128/JVI.19.2.425-434.1976.
10
Spontaneous production of human interferon.人干扰素的自发产生
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5938-42. doi: 10.1073/pnas.77.10.5938.

引用本文的文献

1
Structure and properties of human interferon-alpha from Namalwa lymphoblastoid cells.来自Namalwa淋巴母细胞系的人α干扰素的结构与特性
Biochem J. 1982 Dec 1;207(3):397-408. doi: 10.1042/bj2070397.
2
Use of an anti-human leukocyte interferon monoclonal antibody for the purification and radioimmunoassay of human alpha interferon.一种抗人白细胞干扰素单克隆抗体在人α干扰素纯化及放射免疫测定中的应用。
Infect Immun. 1982 Sep;37(3):919-26. doi: 10.1128/iai.37.3.919-926.1982.
3
Size characteristics of human leucocyte interferon under reducing and non-reducing conditions.
还原和非还原条件下人白细胞干扰素的大小特征
Biochem J. 1981 Mar 1;193(3):947-51. doi: 10.1042/bj1930947.
4
Differences between human alpha (leukocyte) and beta (fibroblast) interferons.人α(白细胞)干扰素和β(成纤维细胞)干扰素之间的差异。
Arch Virol. 1981;67(4):267-81. doi: 10.1007/BF01314831.
5
Enzymatic modifications of human fibroblast and leukocyte interferons.人成纤维细胞干扰素和白细胞干扰素的酶促修饰
J Virol. 1980 Aug;35(2):390-9. doi: 10.1128/JVI.35.2.390-399.1980.
6
Glycosylation of human leukocyte interferon: effects of tunicamycin.人白细胞干扰素的糖基化:衣霉素的作用
Arch Virol. 1980;64(2):109-17. doi: 10.1007/BF01318014.
7
Human leukocyte interferon: relationship between molecular structure and species specificity.人白细胞干扰素:分子结构与种属特异性之间的关系
Proc Natl Acad Sci U S A. 1979 Aug;76(8):3717-21. doi: 10.1073/pnas.76.8.3717.
8
Human leukocyte interferon: production, purification to homogeneity, and initial characterization.人白细胞干扰素:生产、纯化至均一性及初步特性鉴定
Proc Natl Acad Sci U S A. 1979 Feb;76(2):640-4. doi: 10.1073/pnas.76.2.640.